1. $ENTA: New SEC Filing for ENTA: Form 10-Q, No. 0001193125-16-455395 http://stocknewsflow.com/1177648_000119312516455395_0001193125-16-455395

  2. Enanta Pharmaceuticals Inc Just Filed Its Quarterly Report: As of December 31... http://www.conferencecalltranscripts.org/Q/summary2/?id=2409069 $ENTA

  3. $BLPH $ENTA $BDC $ETE $CBM $MXL $SGI $CCXI $WTW $MYM $NYMX $TEN $CBRX

  4. Market Midday % $BLPH +46 $TRXC +19 $BDC +18 $NEOS +18 $NYMX +17 $ENTA +16 $GLT +15 $MSON +14 $CBM +14 $CCXI +15 $ASEI -29 $PAGP -25

  5. Top % Gainers: $BLPH 61%, $ENTA 21%, $BDC 18%, $ETE 18%, $CBM 18%, $MXL 15%, $SGI 15%, $CCXI 14%, $WTW 13%, $MYM 13%, $NYMX 12%, $TEN $CBRX

  6. $ENTA Jumping in here.

  7. $ENTA Squeeeeeze!!!

  8. here you go $ENTA

  9. $ENTA

  10. $ENTA watching for short HOD

  11. $ENTA nice

  12. $ENTA ,,Enanta Pharma Reports Q1 EPS $1.36 vs. Est. $1.13, Rev. $48.445M vs. Est. $47.05M

  13. $ENTA just posted a new conference call. Listen now: http://www.earningscalls.co/stocks/enta

  14. $ENTA Net income for $ENTA Dec Qtr was $26.2 million, $1.36 per share, compared vs $42.0 million or $2.18 same period 2014. No position.

  15. $ENTA: New SEC Filing for ENTA: Form 8-K, No. 0001193125-16-453842 http://stocknewsflow.com/1177648_000119312516453842_0001193125-16-453842

  16. $ENTA Enanta Pharma beats by $0.23, beats on revenue

  17. Enanta Pharmaceuticals Reports Financial Results For Its http://www.conferencecalltranscripts.org/8/summary/?id=2403912 $ENTA

  18. $ENTA Enanta Pharma Reports Q1 EPS $1.36 vs. Est. $1.13, Rev. $48.445M vs. Est. $47.05M

  19. Enanta Pharma Reports Q1 EPS $1.36 vs. Est. $1.13, Rev. $48.445M vs. Est. $47.05M $ENTA

  20. $ENTA is reporting today AMC, and is a potential signal for today EPS est $1.13 Rev est $47.05M @InvestieComp

  21. Earnings-Impact to Keep an Eye on Monday $PAGP, $YELP, $CSCD, $HAS, $BRS, $ENTA, $LII, $PINC, $OTTR, $FOX, $PSDV http://crweworld.com/article/markets/17531/notable-companies-earnings-reports-to-watch-for-monday-february-08-2016

  22. Most definite bounce candidates in biotech $SGEN $ENTA $DVAX $CMRX

  23. Tieton Capital Management, LLC appears to have added to its $ENTA position in the most recent quarter http://www.conferencecalltranscripts.org/summaryh/?id=2398877

  24. $ENTA ABBV up 5% and this continues to absolutly no love despite buying pressure. whatever

  25. $ENTA: New SEC Filing for ENTA: Form SC 13G/A, No. 0001144204-16-078709 http://stocknewsflow.com/1177648_000114420416078709_0001144204-16-078709